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Background: Little is known about the perinatal development of paneth cells (PCs) 
during gestation and the relation with NEC.  We aimed to investigate when PCs 
arise and when they become immune competent during gestation. 
Methods: We included 57 samples of ileum tissue of fetuses/infants with a gestational 
age (GA) between 9 – 40 weeks taken as part of a standard autopsy procedure. 
Hematoxylin-eosin staining and anti-human defensin 5 immunohistochemistry were 
performed. We performed a semi-quantitative assessment of (immune competent) 
PC numbers per 10 crypts per tissue section per GA.
Results: The number of PCs and the number of immune competent PCs increased 
with increasing GA (Spearman’s rho=0.41, p=0.002 and rho=0.61, p<0.001, 
respectively).  Whilst signiﬁ cantly higher PC numbers were observed after 37 weeks’ 
gestation (median 7, range 0 – 12) compared to preterm infants (median 0, range 
0–15; p=0.002), we counted higher numbers of immune competent PCs already in 
infants with GA above 29 weeks (median 6, range 0 – 18) compared to infants with 
GA under 29 weeks (median 2, range 0 – 9; p<0.001). 
Conclusion: The signiﬁ cant increase of immune competent PCs starting from a GA 











Paneth cells (PCs) are specialized epithelial immune cells located in the base of the 
crypts of Lieberkühn located in the small intestine.1,2 PCs can be seen in the gut 
by the ﬁ rst trimester and are thought to mature during gestation1,2 PCs protect the 
intestinal stem cells from pathogens by stimulating stem cell differentiation, shaping 
the intestinal microbiota, and assist in reparation of the gut.2 To this end, they secrete 
(among other things) human alpha-defensins (HD5/HD6).3 These defensins protect 
the intestinal mucosa against bacterial invasion, and are thought to be associated 
with initiating and adapting immunity.3 How PCs develop after the ﬁ rst trimester and 
when PCs become immune competent remains uncertain. 
PCs are thought to contribute to the development of NEC, a common and devastating 
disease most commonly observed in preterm infants.4–6 NEC involves the preterm 
intestine and has a complex pathophysiology in which bacterial invasion and an 
excessive inﬂ ammatory response is an important contributing factor.5,6 Unfortunately 
the exact pathophysiology is incompletely understood. 
It has been hypothesized that maturation of immune competent PCs is crucial for NEC 
development.4,6–8 In the preterm gut, PCs secrete defensins that might contribute to 
an excessive inﬂ ammatory response as observed in NEC.4 This hypothesis is derived 
from the observation that extremely-low-birth-weight (ELBW) human infants generally 
have the longest interval before the onset of NEC - with a peak incidence at the 
postmenstrual age of 29-33 weeks.4,6–8 Despite the possible role for PC-maturation in 
the pathophysiology of NEC, little is known about PC-maturation and functioning in 
the immature intestine. Therefore, we aimed to investigate when PCs arise and when 
they become immune competent in human tissue during gestation.
Methods
Patients
This retrospective study was conducted in a tertiary referral NICU center. The archives 
of the department of Pathology & Medical Biology were searched for fetal and neonatal 
ileum tissue taken as part of a standard autopsy procedure. Tissue samples from cases 
with a gestational age (GA) between 0 and 40 weeks were selected. GA between 0 and 40 
weeks were divided in four- week intervals. Upon retrieval from the archive Hematoxylin-
eosin (HE) stained sections were reviewed. Only those with an intact mucosa without 
injury or autolysis were selected for the study. We excluded autopsy material from patients 
who died two days or more postpartum to minimize the possible external inﬂ uences on 
PC development. We attempted to include eight fetuses/infants per four-week interval of 
GA. Parental consent was not needed to utilize the tissue samples following the WMO 
Medical Research Involving Human Subjects Act requirements. This study was approved 









Tissue modifi cation and immunohistochemistry
After sampling ileum tissue was ﬁ xed in 10% buffered formalin, embedded in 
parafﬁ n, and 4 µm-thick serial sections were prepared. Parafﬁ n-embedded sections 
were stained with HE. Tissue morphology was qualitatively assisted by two trained 
observers (FH and AT).
To determine PC-speciﬁ c expression of HD5, we performed immunohistochemistry. 
Deparafﬁ nized sections (4 µm) were subjected to heat-induced antigen retrieval by 
15 min incubation in 1 mM EDTA buffer (pH 8.0) at 95°C. Endogenous peroxidase was 
blocked for 30 min with 0.075% H2O2 in PBS. Primary antibody Cat. No. MABF31, 
Anti-alpha Defensin 5, clone 8C8 (Merck Millipore, Billerica, MA, USA) was diluted 
1/100 in 1% BSA/PBS, were incubated for 60 min at room temperature. Binding was 
detected using sequential incubations (30 min) with rabbit-anti-mouse peroxidase-
labeled secondary antibody (DakoCytomation, Glostrup, Denmark) and goat-anti-
rabbit peroxidase-labeled tertiairy antibody (DakoCytomation) diluted in PBS with 
1% BSA and 1% normal human serum. Peroxidase activity was developed using 
3,3’-diaminobenzidine tetrachloride (DAB) for 10 min. Sections were counterstained 
with HE. Evaluation of a positive control of immunohistochemistry was done in 
normal human transverse colon tissue.
PC count
Ileum tissue samples were used for analysis to accomplish greater equality during 
the following analysis.  We scored number of PCs per 10 crypts per tissue section 
with HE staining, in random order determined by the observer and blinded for GA, 
using microscopy at a magniﬁ cation of 400x. PCs were identiﬁ ed based on their 
eosinophilic granules and incident light ﬂ uorescence.9 The numbers of PCs were 
scored starting from the ﬁ rst uninterrupted undamaged tissue at the lower right 
region of the tissue section for the length of 10 crypts. Next, we performed a semi-
quantitative assessment of the numbers of immune competent PCs based on HD5 
positive cells. Whereas we have to point out that HD5 immunohistochemistry is 
a more sensitive method for detecting PCs than routine HE staining.10 PCs were 
scored as described above. All scores were given by one observer and validated 
by the second observer blinded for the results of the ﬁ rst observer, after which the 
intra-observer variability was assessed.
Analysis and statistics
First, to investigate when PCs arise in the developing intestine, we analyzed PC 
numbers in the HE stained sections per GA via PC count in each section. Secondly, 
to investigate immune competency (maturity) of PCs per GA, we counted all PCs in 









Inter-observer variability was analyzed using intraclass correlation coefﬁ cients (ICC). 
Comparison between PC counts per GA group was performed using the Kruskal-
Wallis test considering our data as non-normally distributed. The Mann Whitney U test 
was used to assess differences between (each) GA group(s) in case of a signiﬁ cant 
difference found using the Kruskal-Wallis test. For comparison between two 
categorical variables the χ2 analysis was used, the Spearman rho-test for continuous 
variables and the Mann Whitney U test was used for the combination of a categorical 
and a continuous variable, as appropriate. Statistical analyses were performed using 
the Statistical Package for the Social Sciences (IBM SPSS Statistics 21, IBM Corp., 
Armonk, New York, USA). Data were presented as median with range, unless speciﬁ ed 
otherwise. Two sided p-values less than 0.05 were considered signiﬁ cant. 
Results
Patients
We included ileum tissue from 57 fetuses/infants born between June 2003 and June 
2014. The fetuses/infants were divided into eight groups based upon gestational 
age (GA) in weeks (1: 9-12, 2: 13-16, 3: 17-20, 4: 21-24, 5: 25-28, 6: 29-32, 7: 33-
36, 8: 37-40).  Eight fetuses/infants were included per group, except for groups 1 
(n=2) and 5 (n=7). Major causes for death were intra-uterine fetal death (n=17; 30%) 
and clinically indicated termination of pregnancy for fetal or maternal disease (n=16; 
28%). Six infants died two days post partum. We present the patient characteristics 




Gestational age in weeks, median (range) 26 (9 - 40) 
Sex (male), n (%) 32 (56)
Birth weight (grams), median (range) 627 (11 - 4756)
Survival period, n (%)
  Zero days 37 (65)
  One day 14 (25)
  Two days 6 (10)
Cause of death, n (%)
  Intra-uterine fetal death 17(30)
  Clinically indicated termination 16(28)
  Respiratory/circulatory insufﬁ ciency 11 (19)
  Live birth, other causes of death 13 (23)










Figures 1 and 2 and Table 2 show (total numbers of) PCs that stained positively 
with HE staining. Intra-observer variability for the PC count was excellent (ICC 0.95 
(95% CI: 0.91 - 0.97)). GA correlated positively and strongly with the number of 
PCs (rho=0.41, p=0.002). We observed a signiﬁ cant difference between the eight 
groups in terms of PC numbers, using the Kruskal-Wallis test (p=0.02). Signiﬁ cantly 
higher numbers of PCs were counted in infants with a GA above 37 weeks (median 
7, range 0 - 12) compared to all preterm infants (median 0, range 0 - 15; p=0.002). 
No signiﬁ cant differences in total PC counts were found between the groups before 
the GA of 37 weeks (values are depicted in Table 2). Supplemental ﬁ gure S1 and 
supplemental table S1 present detailed patient characteristics and PC count. 
FIGURE 1:
Paneth cells (PCs) HE staining and anti-HD 5 immunohistochemistry
PCs on HE staining are characterized by their rose color, eosinophilic granules, 
incident light fl uorescence and their location in the crypts. Immune competent PCs 
on anti-HD5 staining are characterized by the brown color and their location in the 
crypts. Figure A and B show tissue of a patient with a GA of 20 weeks. No PCs or 
immune competent PCs are observed. Figure C and D show tissue of a patient 
with a GA of 37 weeks. Multiple PCs are observed (the arrow indicates a (immune 










Boxplot of numbers of (immune competent) PCs
Y-as represents number of (immune competent) PCs per crypt, whereas        represents 
numbers of PCs on HE staining, and        represents numbers of (immune competent) 
PCs on anti-HD5 staining. Numbers of PCs were scored per 10 crypts per tissue 
section in random order. The bars represent interquartile range (Q3-Q1), the whiskers 










Differences in (immune competent) PC count per GA
Anti-HD 5 immunohistochemistry PC count
Figures 1 and 2 and Table 2 show (total numbers of) immune competent PCs. Intra-
observer variability for the PC count was excellent (ICC 0.98 (95% CI: 0.98 – 0.99)). 
GA correlated positively and strongly with the number of immune competent PCs 
(rho=0.61, p<0.001). Kruskal-Wallis test demonstrated a signiﬁ cant difference 
between the eight groups in terms of immune competent PC numbers (p=0.001). In 
infants with a GA of 29 weeks or greater had signiﬁ cantly more immune competent 
PCs (median 6, range 0 – 18) when compared to infants with a GA of less than 
29 weeks (median 2, range 0 – 9; p<0.001). When infants became term (GA of 37 
weeks) even higher numbers of immune competent PCs (median 10, range 3 – 
18) were observed when compared to preterm infants (GA <37 weeks; median 3; 
range 0 – 17; p=0.003). Supplemental ﬁ gure S1 and supplemental table S1 present 
detailed patient characteristics and PC count.
 GA 9-12 GA 13-16 GA 17-20 GA 21-24 GA 25-28 GA 29-32 GA 33-36 GA 37-40
PC numbers  0 (0-0) 0 (0-2) .5 (0-15) 0 (0-3) 0 (0-0) 2 (0-6) 2 (0-6) 6.5 (0-12)
HE staining
Immune competent 0 (0-1) 1 (0-4) 3 (0-7) 3 (0-9) 2 (0-8) 5 (0-12) 6 (3-17) 10 (3-18)
PC numbers
(HD5 expression)
GA 13-16 0.64**  0.10* 0.49* 0.39* 0.07* 0.16* 0.008*
GA 17-20 0.19** 0.24**  0.28* 0.05* 0.65* 0.80* 0.16*
GA 21-24 0.11** 0.07** 0.92**  0.20* 0.47* 0.41* 0.02*
GA 25-28 0.29** 0.36** 0.52** 0.38**  0.20* 0.47* 0.41*
GA 29-32 0.09** 0.02** 0.29** 0.22** 0.12**  0.57* 0.09*
GA 33-36 0.03** 0.002** 0.02** 0.02** 0.013** 0.18**  0.05*
GA 37-40 0.04** 0.002** 0.02** 0.011** 0.007** 0.09** 0.71**
Data are expressed as median (range) or as numbers unless specifi ed otherwise. Comparison between 
PC counts per GA group was performed using the Kruskal-Wallis test. The Mann Whitney U test was 
used to assess differences between (each) GA group(s) in case of a signifi cant difference found using 
the Kruskal-Wallis test. Signifi cance is shown by boldfaced values. * p-values represent GA versus PC 










Although a role for PCs in the pathophysiology of NEC has been suggested, little 
is known about the PC number and functioning in the immature human gut and 
its relation with the development of NEC. The present study suggests that the 
number of PCs increases rapidly after a GA of 37 weeks. However, starting from 
29 weeks of gestation, we observed a rapid increase in immune competent PCs as 
demonstrated by the expression of defensin HD5. This corresponds with the peak 
incidence of NEC occurring at a postmenstrual age of 29-33 weeks. When taken 
together, these observations suggest a putative role for immune competent PCs in 
the pathophysiology of NEC. 
Most insights on PC development and functioning are from murine studies. Their 
epithelium is immature at birth and undergoes extensive postnatal remodeling and 
crypt ontogeny after birth.11 These animal studies are not directly comparable with 
human tissue because human PCs are thought to develop during the ﬁ rst trimester 
of gestation.11 According to current laboratory studies using gene expression 
- and intestinal isografts, PCs develop during the ﬁ rst trimester of gestation and 
increase in numbers by term gestation.1,11,12 The present study could not conﬁ rm the 
development of PCs during the ﬁ rst trimester, which is possibly the result of the only 
moderate sensitivity of HE staining.10 However, we did observe signiﬁ cantly higher 
numbers of PCs at term gestation. 
It has been suggested that  PCs start producing defensins, including HD5 around a 
GA of 13 weeks.4 Both PC numbers and defensins expression are hypothesized to 
be lower in preterm infants with a GA of 24 weeks compared with term infants.1,13
According to our current understanding, the appearance of HD5 coincides 
approximately with PC differentiation during intestinal crypt ontogeny.1113 The 
present study suggests that HD5 expression coincides with PC development until 
a GA of 28 weeks; in the period starting from 29 weeks of GA, HD5 expression 
increases more rapidly than the number of PCs.
PCs with their defensin expression, such as HD5, play a key role in the intestinal 
innate immunity and development of diseases.14–16 PCs with their defensin 
expression are previously described in the pathophysiology of Crohn’s disease.16
The present study hypothesizes associations between PC defensin expression and 
NEC. This hypothesis is based on the ﬁ nding that the increase of HD5 expression 
by PCs equals the peak incidence of NEC at a postmenstrual age of 29-33 weeks, 










The current hypotheses on the role of PCs in NEC development are based on 
either depletion of PCs, increased immune activity of PCs or PC dysfunction6,8,9
In the ﬁ rst hypothesis, it is suggested that there is a relative deﬁ ciency of (immune 
competent) PCs at a low GA.4,17 This deﬁ ciency could lead to a limited protection 
against opportunistic and/or pathogenic bacteria involved in NEC development.4,17
Our data is not consistent with this hypothesis, because we observed a signiﬁ cant 
increase of immune competent PCs during gestation and not depletion. In the 
second hypothesis, the secretion of antimicrobial peptides by the PCs might 
be over-activated in the immature immune system leading to an overwhelming 
inﬂ ammatory response.1,18,19 This exaggerated infl ammatory response could lead 
to increased intestinal damage, bacterial dysbiosis and reduced epithelial repair 
which in turn would lead to the development of NEC.1,18,19 With the results of the 
present study, one could speculate that the rapid increase of defensin expression 
around a GA of 29 weeks, in combination with colonization with opportunistic and/
or pathogenic pathogens and a still premature intestine, triggers NEC development. 
The last hypothesis assumes a dysfunction of PCs by environmental stressors: 
dysfunction of PCs may be an early event that predisposes the preterm infant to 
NEC by inducing bacterial dysbiosis.1,20,21 This hypothesis could, however, not be 
tested in the present study and should be subject of future research.
We acknowledge several limitations in the present study. First, epithelial 
differentiation from common progenitor stem cells, including the differentiation into 
PCs, is controlled by transcription factors, such as Math 1, under the control of 
the Wnt and Notch signaling pathways starting during crypt morphogenesis within 
the ﬁ rst trimester of pregnancy.13,22 It is not yet known how this pathway further 
develops during gestation, e.g. when it reaches its maximum and if it inﬂ uences HD5 
expression of the PCs. We could therefore not relate the inﬂ uence of the epithelial 
differentiation pathway to the results of the present study. Future studies should 
focus on elucidating signaling pathways mediating PC formation – such as the Wnt 
and Notch signaling pathways - and function in the premature intestine. Second, 
the population size is small. However, this study is to our knowledge the ﬁ rst study 
focusing on the emergence and immune competence of PCs per GA performed in 
human tissue. Third, we only studied anti-HD5, whilst there are more antimicrobial 
products secreted by PCs that could be of interest (i.e. HD6, sPLA2, lysozymes, 
Reg3G).17However, of the antimicrobial expression of PCs, HD5 is responsible for 
the majority of total antimicrobial expression.17 In line with Shen et al.21 the data of 
the present study indicates that HD5 immunohistochemistry is a more sensitive 
method for detecting PCs than routine HE staining that could have inﬂ uenced our 









into the numbers of PCs, potentially without immune competency. Lastly, we did not 
use NEC tissue for our analysis, and therefore the exact relation between PCs and 
NEC development remains speculative. Unfortunately, NEC resection specimens 
were too damaged for PC analysis according to our methods and, thereby, only give 
insight at the end stage of the disease rather than in the early development stage 
of NEC. 
A key deﬁ ciency in our understanding of PCs is still the mechanisms that underlie their 
formation during development. We also do not understand the signaling pathways 
that mediate PC formation and their behaviour during critical events during late 
fetal and perinatal development.23 Understanding of these pathways together with 
the knowledge of our study, will shed light on PC development in human intestinal 
tissue. The considerable increase of antimicrobial expression of the PCs starting 
from 29 weeks’ GA could lead to an excessive inﬂ ammatory response which is seen 
in NEC.
Conclusion
With the present study we were able to investigate when PCs arise and when they 
become immune competent in human tissue during gestation. We observed that 
while the number of PCs signiﬁ cantly increased when infants became term, the 
increase of immune competent PCs increased signiﬁ cantly starting from 29 weeks 
of gestation, which equals the peak incidence of NEC at a postmenstrual age of 29-
33 weeks. Whether this association between PCs and NEC is a causal one remains 
to be seen. 
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Supplemental table S1: Detailed patient characteristics
 GA  Gender Weight Nature of specimen Number of PCs Number of PCs
 (weeks)  (grams)  HE staining anti-HD5 staining
1 9 Male 11 Termination of pregnancy 0 0
2 12 male 15 Termination of pregnancy 0 1
3 14 Male 32 Intra-uterine death 0 1
4 15 Male 94 Intra-uterine death 0 2
5 15 Male 55 Termination of pregnancy 0 1
6 15 Unknown unknown Intra-uterine death 0 0
7 16 Unknown unknown Termination of pregnancy 0 0
8 16 Unknown unknown Termination of pregnancy 2 0
9 16 Female 82 Termination of pregnancy 0 0
10 16 Male 75 Termination of pregnancy 0 4
11 17 Male 164 Intra-uterine death 0 0
12 19 Male 210 Intra-uterine death 1 3
13 19 Male 19 Termination of pregnancy 0 3
14 19 Female 80 Termination of pregnancy 0 2
15 19 Female 532 Termination of pregnancy 0 0
16 20 Female 218 Intra-uterine death 3 7
17 20 Female 226 Termination of pregnancy 3 4
18 20 Female 302 Intra-uterine death 2 4
19 21 Male 410 Termination of pregnancy 15 6
20 21 Female 312 Termination of pregnancy 0 4
21 22 Female 438 Termination of pregnancy 0 1
22 22 Male 610 Respiratory/circulatory 0 9
    insufﬁ ciency
23 23 Male 610 Termination of pregnancy 3 5
24 24 Female 570 Intra-uterine death 0 2
25 24 Male 588 Respiratory/circulatory 2 2
    insufﬁ ciency
26 24 Female 336 Live birth, other 0 6
    causes of death
27 25 Male 550 Intra-uterine death 6 0
28 25 Male 644 Intra-uterine death 0 3
29 26 Male 556 Intra-uterine death 0 2
30 26 Male 946 Intra-uterine death 0 8
31 26 Male 870 Intra-uterine death 0 1
32 28 Female 318 Intra-uterine death 0 0
33 28 Female 600 Respiratory/circulatory 0 3
    insufﬁ ciency
34 30 Unknown 1656 Live birth, other 0 3
    causes of death
35 30 Male 2046 Live birth, other 4 10
    causes of death
36 31 Female 2200 Live birth, other 0 5
    causes of death
37 32 Male 1092 Live birth, other 6 12
    causes of death
38 32 Male 2120 Live birth, other 0 0









39 32 Male 1850 Live birth, other 0 2
    causes of death
40 32 Male 2124 Live birth, other 4 6
    causes of death
41 32 Male 1558 Termination of pregnancy 4 5
42 33 Male 1165 Live birth, other 0 3
    causes of death
43 33 Male 2450 Live birth, other 6 17
    causes of death
44 34 Female 2554 Respiratory/circulatory 2 6
    insufﬁ ciency
45 34 Male 3750 Live birth, other 3 6
    causes of death
46 34 Male 1720 Intra-uterine death 0 6
47 34 Male 1570 Respiratory/circulatory 2 6
    insufﬁ ciency
48 36 Male 2486 Respiratory/circulatory 0 8
    insufﬁ ciency
49 36 Female 2172 Intra-uterine death 0 8
50 37 Male 3359 Respiratory/circulatory 0 6
    insufﬁ ciency
51 37 Male 3820 Live birth, other 3 5
    causes of death
52 39 Female 2110 Respiratory/circulatory 12 18
    insufﬁ ciency
53 40 Female 4756 Respiratory/circulatory 7 18
    insufﬁ ciency
54 40 Female 4236 Respiratory/circulatory 10 14
    insufﬁ ciency
55 40 Female 3800 Intra-uterine death 0 3
56 40 Female 3456 Respiratory/circulatory 6 14
    insufﬁ ciency
57 40 female 3000 Live birth, other 12 5
    causes of death
72
SUPPLEMENTAL FIGURE S1:
Gestational age versus number of (immune competent) PCs
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